Ebola and Marburg viruses

Pathogenesis and development of countermeasures

Lisa E. Hensley, Steven M. Jones, Heinz Feldmann, Peter B. Jahrling, Thomas Geisbert

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Ebola and Marburg viruses, family Filoviridae, are among the best known examples of emerging and re-emerging pathogens. Although outbreaks have been sporadic and geographically restricted to areas of Central Africa, the hemorrhagic fevers caused by these viruses are remarkably severe and are associated with high case fatality rates often exceeding 80 percent. In addition to humans, these viruses have decimated populations of wild apes in Central Africa. Currently, there are no vaccines or effective therapies available for human use. Progress in understanding the geneses of the pathophysiological changes that make filoviral infections of humans so destructive has been slow, primarily because these viruses require special containment for safe research. However, an increasing understanding of the molecular mechanisms of filoviral pathogenesis, facilitated by the development of new tools to elucidate critical regulatory elements in the viral life cycle, is providing new targets that can be exploited for therapeutic interventions. In addition, substantial progress has been made in developing recombinant vaccines against these viruses.

Original languageEnglish (US)
Pages (from-to)761-772
Number of pages12
JournalCurrent Molecular Medicine
Volume5
Issue number8
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Marburgvirus
Ebolavirus
Viruses
Central Africa
Filoviridae
Synthetic Vaccines
Hominidae
Life Cycle Stages
Disease Outbreaks
Pathogens
Fever
Vaccines
Life cycle
Mortality
Therapeutics
Infection
Research
Population

ASJC Scopus subject areas

  • Biochemistry

Cite this

Ebola and Marburg viruses : Pathogenesis and development of countermeasures. / Hensley, Lisa E.; Jones, Steven M.; Feldmann, Heinz; Jahrling, Peter B.; Geisbert, Thomas.

In: Current Molecular Medicine, Vol. 5, No. 8, 12.2005, p. 761-772.

Research output: Contribution to journalArticle

Hensley, Lisa E. ; Jones, Steven M. ; Feldmann, Heinz ; Jahrling, Peter B. ; Geisbert, Thomas. / Ebola and Marburg viruses : Pathogenesis and development of countermeasures. In: Current Molecular Medicine. 2005 ; Vol. 5, No. 8. pp. 761-772.
@article{fc4036efdb6442afb911516ff6b800a1,
title = "Ebola and Marburg viruses: Pathogenesis and development of countermeasures",
abstract = "Ebola and Marburg viruses, family Filoviridae, are among the best known examples of emerging and re-emerging pathogens. Although outbreaks have been sporadic and geographically restricted to areas of Central Africa, the hemorrhagic fevers caused by these viruses are remarkably severe and are associated with high case fatality rates often exceeding 80 percent. In addition to humans, these viruses have decimated populations of wild apes in Central Africa. Currently, there are no vaccines or effective therapies available for human use. Progress in understanding the geneses of the pathophysiological changes that make filoviral infections of humans so destructive has been slow, primarily because these viruses require special containment for safe research. However, an increasing understanding of the molecular mechanisms of filoviral pathogenesis, facilitated by the development of new tools to elucidate critical regulatory elements in the viral life cycle, is providing new targets that can be exploited for therapeutic interventions. In addition, substantial progress has been made in developing recombinant vaccines against these viruses.",
author = "Hensley, {Lisa E.} and Jones, {Steven M.} and Heinz Feldmann and Jahrling, {Peter B.} and Thomas Geisbert",
year = "2005",
month = "12",
doi = "10.2174/156652405774962344",
language = "English (US)",
volume = "5",
pages = "761--772",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Ebola and Marburg viruses

T2 - Pathogenesis and development of countermeasures

AU - Hensley, Lisa E.

AU - Jones, Steven M.

AU - Feldmann, Heinz

AU - Jahrling, Peter B.

AU - Geisbert, Thomas

PY - 2005/12

Y1 - 2005/12

N2 - Ebola and Marburg viruses, family Filoviridae, are among the best known examples of emerging and re-emerging pathogens. Although outbreaks have been sporadic and geographically restricted to areas of Central Africa, the hemorrhagic fevers caused by these viruses are remarkably severe and are associated with high case fatality rates often exceeding 80 percent. In addition to humans, these viruses have decimated populations of wild apes in Central Africa. Currently, there are no vaccines or effective therapies available for human use. Progress in understanding the geneses of the pathophysiological changes that make filoviral infections of humans so destructive has been slow, primarily because these viruses require special containment for safe research. However, an increasing understanding of the molecular mechanisms of filoviral pathogenesis, facilitated by the development of new tools to elucidate critical regulatory elements in the viral life cycle, is providing new targets that can be exploited for therapeutic interventions. In addition, substantial progress has been made in developing recombinant vaccines against these viruses.

AB - Ebola and Marburg viruses, family Filoviridae, are among the best known examples of emerging and re-emerging pathogens. Although outbreaks have been sporadic and geographically restricted to areas of Central Africa, the hemorrhagic fevers caused by these viruses are remarkably severe and are associated with high case fatality rates often exceeding 80 percent. In addition to humans, these viruses have decimated populations of wild apes in Central Africa. Currently, there are no vaccines or effective therapies available for human use. Progress in understanding the geneses of the pathophysiological changes that make filoviral infections of humans so destructive has been slow, primarily because these viruses require special containment for safe research. However, an increasing understanding of the molecular mechanisms of filoviral pathogenesis, facilitated by the development of new tools to elucidate critical regulatory elements in the viral life cycle, is providing new targets that can be exploited for therapeutic interventions. In addition, substantial progress has been made in developing recombinant vaccines against these viruses.

UR - http://www.scopus.com/inward/record.url?scp=29444441054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29444441054&partnerID=8YFLogxK

U2 - 10.2174/156652405774962344

DO - 10.2174/156652405774962344

M3 - Article

VL - 5

SP - 761

EP - 772

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 8

ER -